Role of Helicobacter in functional dyspepsia

World Journal of Gastroenterology

Volumn 12, Issue 17, 2006, Pages 2677-2680

  O'Morain, Colm ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Functional dyspepsia; Helicobacter pylori; Triple therapy; Urea breath test

Indexed keywords

ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT; PROTON PUMP;

ARTICLE; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG PENETRATION; DYSPEPSIA; ERADICATION THERAPY; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE COST; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; NON INVASIVE MEASUREMENT; PATHOGENESIS; PREVALENCE; RELIABILITY; RISK REDUCTION; SYSTEMATIC REVIEW; UREA BREATH TEST; BREATH ANALYSIS; CLASSIFICATION; DOSE RESPONSE; DRUG ANTAGONISM; ENDOSCOPY; FECES; MICROBIOLOGY; PATHOPHYSIOLOGY; REVIEW; TIME;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BREATH TESTS; CLARITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSPEPSIA; ENDOSCOPY; FECES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; PROTON PUMPS; TIME FACTORS;

EID: 33744469607     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i17.2677     Document Type: Article

References (31)

1. O'Morain C, Gilvarry J. Eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Scand J Gastroenterol 1993; 196 Suppl: 30-33
2. Mc Namara DA, Buckley M, O'Morain CA. Nonulcer dyspepsia. Current concepts and management. Gastroenterol Clin North Am 2000; 29: 807-818
3. Lee JM, Deasy E, O'Morain CA. Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice. Eur J Gastroenterol Hepatol 2000; 12: 433-437
4. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180
5. AGA. American Gastroenterology Association Medical Position Statement: Evaluation of Dyspepsia. Gastroenterology 2005; 129: 1753-1755
6. Chiba N, Veldhuyzen Van Zanten SJ, Escobedo S, Grace E, Lee J, Sinclair P, Barkun A, Armstrong D, Thomson AB. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. Aliment Pharmacol Ther 2004; 19: 349-358
7. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Delaney B. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000; 321: 659-664
8. Silverstein MD, Petterson T, Talley NJ. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996; 110: 72-83
9. Fendrick AM, Chernew ME, Hirth RA, Bloom BS. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995; 123: 260-268
10. Ofman JJ, Etchason J, Fullerton S, Kahn KL, Soll AH. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences. Ann Intern Med 1997; 126:280-291
11. Sonnenberg A, Townsend WF, Muller AD. Evaluation of dyspepsia and functional gastrointestinal disorders: a cost-benefit analysis of different approaches. Eur J Gastroenterol Hepatol 1995; 7: 655-659
12. Briggs AH, Sculpher MJ, Logan RP, Aldous J, Ramsay ME, Baron JH. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ 1996; 312:1321-1325
13. Rich M, Scheiman JM, Tierney W, Fendrick AM. Is upper gastrointestital radiography a cost-effective alternative to a Helicobacter pylori "test and treat" strategy for patients with suspected peptic ulcer disease? Am J Gastroenterol 2000; 95: 651-658
14. Ladabaum U, Chey WD, Scheiman JM, Fendrick AM. Re-appraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis. Aliment Pharmacol Ther 2002; 16:1491-1501
15. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998; 114: 582-595
16. Hallissey MT, Allum WH, Jewkes AJ, Ellis DJ, Fielding JW. Early detection of gastric cancer. BMJ 1990; 301: 513-515
17. Mason JM, Delaney B, Moayyedi P, Thomas M, Walt R. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Aliment Pharmacol Ther 2005; 21: 1135-1143
18. Lassen AT, Hallas J, Schaffalitzky de Muckadell OB. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut 2004, 53: 1758-1763
19. Laheij RJ, van Rossum LG, Heinen N, Jansen JB. Long-term follow-up of empirical treatment or prompt endoscopy for patients with persistent dyspeptic symptoms? Eur J Gastroenterol Hepatol 2004; 16: 785-789
20. McCarthy C, Patchett S, Collins RM, Beattie S, Keane C, O'Morain C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40:114-119
21. Patchett S, Beattie S, Leen E, Keane C, O'Morain C. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ 1991; 303: 1238-1240
22. McNamara D, Buckley M, Gilvarry J, O'Morain C. Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study. Helicobacter 2002; 7: 317-321
23. El-Omar E, Penman I, McColl K E L. A substantial proportion of H pylori positive NUD patients have the same disturbance of acid secretion as DU patients. Gut 1993; 4: S49
24. McColl KE, Fullarton GM, Chittajalu R, el Nujumi AM, MacDonald AM, Dahill SW, Hilditch TE. Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 339-346
25. Levi S, Beardshall K, Swift I, Foulkes W, Playford R, Ghosh P, Calam J. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. BMJ 1989; 299: 1504-1505
26. Prewett EJ, Smith JT, Nwokolo CU, Hudson M, Sawyerr AM, Pounder RE. Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther 1991; 5: 283-290
27. Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-932
28. el-Omar E, Penman I, Dorrian CA, Ardill JE, McColl KE. Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993; 34: 1060-1065
29. Hall W, Buckley M, Crotty P, O'Morain CA. Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin Gastroenterol Hepatol 2003; 1: 363-369
30. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F. Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther 2003; 17: 99-109
31. McLoughlin R, Racz I, Buckley M, O'Connor HJ, O'Morain C. Therapy of Helicobacter pylori. Helicobacter 2004; 9 Suppl 1: 42-48